[The usefulness of 99mTc-MIBI scintigraphy in a patient with hyperparathyroidism who underwent percutaneous ethanol injection therapy].
99mTc-MIBI scintigraphy was performed in a 67-year-old male with hyperparathyroidism who underwent percutaneous ethanol injection therapy (PEIT). Abnormal 99mTc-MIBI uptake was clearly recognized. 99mTc-MIBI scintigraphy was useful also in the evaluation of hyperparathyroidism after imperfect PEIT.